Suh Sarah, Hetzel Emily, Alter-Troilo Katie, Lak Kathleen, Gould Jon C, Kindel Tammy L, Higgins Rana M
Department of Surgery, Division of General Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin.
Department of Surgery, Division of General Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin.
Surg Obes Relat Dis. 2021 Aug;17(8):1480-1488. doi: 10.1016/j.soard.2021.04.014. Epub 2021 Apr 24.
Preoperative carbohydrate loading is a component of Enhanced Recovery After Surgery (ERAS) protocols, but there is limited literature in bariatric surgery patients.
The objective of this study was to characterize the impact of preoperative carbohydrate loading on postoperative bariatric surgery outcomes.
University Hospital.
Patients undergoing a primary minimally invasive Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) between 2018 and 2020 were randomized to standard management or intervention. Standard management patients were nothing by mouth (NPO) after midnight prior to surgery. Intervention patients consumed 2 carbohydrate drinks: 1 the night before and another 3 hours prior to surgery. Primary outcomes analyzed included postoperative nausea and vomiting (PONV), length of stay, and overall complications.
In total, 134 patients were analyzed: 64 intervention (47.8%) and 70 (52.2%) standard. In the end, 7% and 15% of patients were lost to follow-up at 6-weeks and 3-months, respectively. There was no statistically significant difference in length of stay (2.0 ± 1.2 vs 2.1 ± .9 d; P = .65) or postoperative outcomes between the 2 groups. There were no episodes of aspiration among the intervention group. Among RYGB patients, intervention patients had a shorter duration of nausea compared with standard patients. There was no significant difference in glycemic control among patients with and without diabetes.
Preoperative carbohydrate drinks can be administered to bariatric surgery patients without significant risks. Carbohydrate loading preoperatively can decrease the duration of PONV in RYGB patients. Carbohydrate drinks can be safely included in bariatric ERAS protocols for patients with and without diabetes, although the benefits remain unknown.
术前碳水化合物负荷是加速康复外科(ERAS)方案的一个组成部分,但关于减重手术患者的文献有限。
本研究的目的是描述术前碳水化合物负荷对减重手术后结局的影响。
大学医院。
2018年至2020年间接受初次微创Roux-en-Y胃旁路术(RYGB)或袖状胃切除术(SG)的患者被随机分为标准管理组或干预组。标准管理组患者在手术前午夜后禁食禁水。干预组患者饮用2种碳水化合物饮料:术前一晚1次,术前3小时1次。分析的主要结局包括术后恶心呕吐(PONV)、住院时间和总体并发症。
共分析了134例患者:64例(47.8%)为干预组,70例(52.2%)为标准管理组。最终,分别有7%和15%的患者在6周和3个月时失访。两组之间的住院时间(2.0±1.2天 vs 2.1±0.9天;P = 0.65)或术后结局无统计学显著差异。干预组未发生误吸事件。在RYGB患者中,干预组患者的恶心持续时间比标准管理组患者短。糖尿病患者和非糖尿病患者的血糖控制无显著差异。
术前可向减重手术患者给予碳水化合物饮料,且无重大风险。术前碳水化合物负荷可缩短RYGB患者的PONV持续时间。对于糖尿病患者和非糖尿病患者,碳水化合物饮料可安全纳入减重ERAS方案,尽管其益处尚不清楚。